Earnings
SNDL Weighs Direct Ownership Of Parallel's Medical Cannabis Arm After Lifting Stake To About 92%
CEO Zach George says the company will not wait on Washington and wants Parallel's medical business in its recurring earnings.
SNDL news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
CEO Zach George says the company will not wait on Washington and wants Parallel's medical business in its recurring earnings.
Earnings
The CEO says cannabis operations "remain below our expectations" as SNDL exits domestic dried flower and cuts Kelowna jobs by more than 30%.
Earnings
The charge pushed the third-quarter operating result to a C$48.3 million loss, while free cash flow set a quarterly record of C$20.0 million.